Search

everythinglearnresearchcommunity

for

Search:↓

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Voriconazole can cause serious side effects, especially in long-term use.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.